Adjuvant Endocrine Therapy for Early Breast Cancer

Managing luminal HER2-negative early breast cancer requires a thorough understanding of hormone receptor biology and tailored treatment strategies. This text-based course offers a structured introduction to adjuvant endocrine therapy, guiding you from basic clinical terminology to real-world management considerations. You will gain a clear grasp of how endocrine therapies work, how treatment plans are selected based on patient risk profiles, and how to address side effects to support treatment adherence. What you'll learn: - Understand core hormone receptor terminology and tumor biology in early breast cancer - Explore standard endocrine therapy options including selective estrogen receptor modulators and aromatase inhibitors - Evaluate patient risk stratification criteria to guide therapy selection - Learn strategies for managing common adverse effects and improving long-term adherence - Examine modern treatment considerations, including combination approaches with targeted therapies The course begins with fundamental biological concepts and diagnostic criteria before progressing to treatment regimens, risk assessment, and patient care management through clear written explanations and case studies. Designed for medical students, entry-level healthcare professionals, and researchers seeking a clear foundation in oncology concepts. Start reading today to enhance your understanding of endocrine treatment strategies.